HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Radiology & Imaging
Cohort
Retrospective study reports 100% technical success for integrated IVC filter-thrombus retrieval technique
New technique successfully removes blood clot-filled IVC filters in small study
A single-center retrospective cohort of 51 patients with IVC filter thrombosis found the filter-thrombus integrated retrieval technique achi…
A new technique successfully removed blood clot-filled IVC filters in all 51 patients studied, with no serious complications and only minor,…
Frontiers
Apr 3, 2026
Allergy & Immunology
RCT
Mobile App Plus Standard Care Shows Mixed Results for Asthma Control in Malaysian Adults
Can a phone app help adults with asthma breathe easier?
A 6-month RCT of 162 adult asthma outpatients in Malaysia compared the CareAide® mobile app plus standard care to standard care alone.
A phone app helped some Malaysian adults with asthma feel more in control of their breathing after six months of use alongside standard care…
Apr 3, 2026
Pulmonology & Critical Care
RCT
Vitamin D3 supplementation improved exercise tolerance in deficient male COPD patients in small RCT
Vitamin D supplements linked to better walking ability in men with COPD and low vitamin D
A 26-week double-blind RCT in 40 vitamin D3-deficient male COPD patients found that oral vitamin D3 supplementation (80,000 IU/week then adj…
Men with COPD and low vitamin D levels walked farther and felt less breathless after taking supplements for six months.
Apr 2, 2026
Allergy & Immunology
Meta-analysis
Remote digital asthma management shows modest quality of life and lung function improvements in adults
Can asthma apps and websites help adults breathe easier?
A meta-analysis of 10 trials in adults with asthma found interactive remote digital management improved quality of life, symptom control, an…
Digital asthma tools show small lung function gains, but quality of life improvements were modest and didn't reach the threshold for patient…
Frontiers
Apr 2, 2026
Pulmonology & Critical Care
RCT
Acute high-intensity inspiratory muscle training linked to shorter oxygen desaturation time in COPD
Small COPD study finds different breathing exercises affect muscle oxygen differently
A randomized crossover study in 29 individuals with COPD found acute high-load IMT was associated with shorter oxygen desaturation time comp…
High-intensity breathing exercises may drop arm muscle oxygen faster than lower-intensity training in people with COPD, while endurance trai…
Apr 1, 2026
Drug Pipeline
Review proposes immunothrombosis pathway linking pulmonary disease to stroke and neurodegeneration
Researchers propose lung-to-brain inflammation pathway may link breathing problems to stroke risk
A mechanistic review integrates evidence from pulmonary medicine, coagulation biology, stroke pathology, and neurodegeneration research.
Lung inflammation might trigger clotting that travels to the brain, potentially raising stroke risk and affecting long-term brain health.
Frontiers
Apr 1, 2026
Allergy & Immunology
Sys. Review
Asia-Pacific experts propose clinical remission definition and lung function goals for severe asthma
What does it mean to beat severe asthma in Asia? Experts propose new goals
A position statement by Asia-Pacific experts reviewed severe asthma management challenges in the region.
Experts redefine severe asthma success in Asia by prioritizing symptom control and stability over impossible lung function recovery.
Frontiers
Apr 1, 2026
Cardiology
FDA Approval
FDA Approves Xarelto (rivaroxaban) for multiple indications including stroke prevention in nonvalvular atrial fibrillation and treatment of VTE
FDA approves a new blood thinner called Xarelto for several heart and clot conditions
The FDA approved rivaroxaban (Xarelto), a factor Xa inhibitor, for multiple indications including reducing stroke risk in nonvalvular atrial…
FDA approves new blood thinner Xarelto to prevent dangerous clots in heart conditions, deep vein issues, and after major surgeries.
FDA
Mar 31, 2026
Allergy & Immunology
Phase II
VALIANT: Phase 2 trial of verekitug (UPB-101) for severe asthma completes enrollment of 479 patients
Can a new injection help people with severe asthma breathe easier and avoid dangerous flare-ups?
The VALIANT study, a phase 2 trial, evaluated the efficacy and safety of subcutaneous verekitug (UPB-101) versus placebo in adults with seve…
A new asthma injection aims to reduce dangerous flare-ups and improve breathing for adults with severe asthma in a completed trial.
CT.gov
Mar 30, 2026
Allergy & Immunology
Phase III
Pink vs. white inhaler actuators studied for asthma symptom perception in crossover trial
Study compares pink and white asthma inhalers for how patients perceive symptoms
A phase IIIb randomized, double-blind, crossover trial in 78 adults with moderate to severe asthma compared identical beclomethasone/formote…
Asthma patients tried identical inhalers in pink or white to see if color changed how they perceived their symptoms and which device they pr…
CT.gov
Mar 30, 2026
Oncology
RCT
Home treatment for low-risk cancer-associated PE shows 4.6% major bleeding rate in ONCO PE companion report
Could some cancer patients safely treat blood clots at home? New research suggests yes
A predetermined companion report from the ONCO PE trial evaluated 3-month outcomes for home vs.
Active cancer patients with low-risk lung clots can safely take blood thinners at home, avoiding disruptive hospital stays while staying on …
Mar 30, 2026
Allergy & Immunology
Phase IV
Digital albuterol system feasibility studied in 333 asthma patients with suboptimal control
Can a smart inhaler help people with uncontrolled asthma breathe easier?
A phase 4, open-label, multicenter feasibility study randomized 333 participants aged 13+ with suboptimal asthma control to either the Albut…
A new smart inhaler system tested for 12 weeks to see if it helps people with uncontrolled asthma breathe easier, but results are not yet av…
CT.gov
Mar 30, 2026